Numis Securities
Jack McLaren is a seasoned investment banking professional currently serving as a Vice President at Deutsche Numis since September 2018, with a focus on M&A execution. Notable recent transactions include advising Alliance Pharma on its take-private deal from DBAY and providing counsel to PHP on its recommended offer for Assura. Prior experience includes a summer analyst role at Rothschild & Co within the GA Healthcare M&A team, as well as participation in the Oxford Finance Lab at the University of Oxford - Said Business School. Jack also gained research experience at Perm State University, where the focus was on Aromatic & Heterocyclic Chemistry. Jack holds a Master's degree in Chemistry from the University of Oxford, completed in 2018.
This person is not in any teams
This person is not in any offices
Numis Securities
2 followers
Numis Corporation PLC is a United Kingdom-based independent institutional stockbrokers and corporate advisors. The Company offers a range of research, execution, corporate broking and advisory services to companies quoted in the United Kingdom and its investors. The Company's services include research, sales and trading, investment companies, corporate finance, corporate broking, principle capital fund managers limited (PCFM), Numis indices and asset management. The investment company's research-driven approach focuses on specialist or differentiated mandates, including quoted equity, private equity, infrastructure, property, debt and other alternative assets. The corporate finance services include advice and transaction execution in relation to mergers and acquisitions, secondary equity issuance, convertible securities and bonds. The Company serves corporate clients and institutional clients. It is managed as an integrated corporate advisory and stockbroking business.